Rhinovirus Study for Hospitalized Children

The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study

Recruiting Observational Study
Rhinovirus
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 17
Sex
Any
Study type
Observational
Participants needed
670 (estimated)
Sponsor
University of Wisconsin, Madison · Other
Who this trial is looking for

This trial is looking for children who are hospitalized with certain respiratory illnesses caused by Rhinoviruses. Participants will be monitored during their hospital stay and may provide samples for research over several years.

Are You a Good Fit for This Trial?
Rules you out Cerebral palsySeizure disorder

You may be able to join if

  • I have a child under 17.5 years old.
  • I can provide consent in English.
  • My child was admitted to the hospital within the last 24 hours.
  • My child has been diagnosed with a respiratory illness or fever.

You may not be able to join if

  • I have a child with a severe immune condition.
  • I have a child with chronic lung disease, except asthma.
  • My child has had respiratory symptoms in the last week.
  • I have another child already in the study.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this study is to determine the burden of Rhinoviruses (RVs) as a cause of acute, severe, respiratory illnesses leading to hospitalization. A community cohort of 120 children between 12 and 36 months of age will be enrolled in the first year of the study and followed (when well and sick) for 36 months to identify the circulating RVs and provide samples to establish a host nasal transcri…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria (Aim 1 and Aim 2b Community Groups): * Parent/legal guardian is willing and able to provide informed consent in English. * Willing to comply with all study procedures and be available for the duration of the study. * Younger Community Group: Generally healthy children 12 to 36 mo…
Contacts

Research Nurses

608-228-4940

reserachnurses@pediatrics.wisc.edu

CONTACT